Cancer Immunology and Immunotherapy

Access ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.

Tumour Knowledge Portal

Preselected recommended educational resources on this topic

ESMO Clinical Practice Guidelines

Clinical Practice Guidelines block

Check the Clinical Practice Guidelines by Tumour Type to find recommendations

Handbooks

2018 ESMO Handbook of Immuno-Oncology

ESMO Handbook of Immuno-Oncology now available!

Stéphane Champiat reports the findings presented at AACR 2018, in particular the results from a phase III study of pembrolizumab in adjuvant treatment of melanoma, and results from a phase Ib study of Toll-like receptor 9 (TLR-9) agonist in melanoma resistant to anti-PD-1 therapy.